What Crisalix does

Crisalix S.A. is a privately-held Swiss health technology company founded in 2008 and headquartered in Lausanne, Switzerland. It operates a cloud-based 3D, 4D virtual reality, and augmented reality medical aesthetic imaging platform that uses proprietary computer vision and generative AI to produce personalized body visualizations from three standard 2D photographs. The platform serves two primary customer segments: board-certified plastic surgeons and aesthetic practitioners (B2B) who use the 3D Business Platform for in-clinic and remote consultations, and individual patients (B2C) who access the MyCrisalix consumer app for self-serve simulations. The technology stack combines AI-powered 3D reconstruction, a 5,000+ implant reference library from major manufacturers (Allergan, Mentor, Motiva, etc.), 4D VR simulation, AR treatment visualization, and remote consultation capabilities, all delivered through a HIPAA-aligned, GDPR-compliant cloud infrastructure.

The company operates a hybrid revenue model with three streams: recurring surgeon subscription plans for the 3D Business Platform, one-time patient payments starting at $44 USD for self-serve simulations, and OEM/white-label licensing through partnerships such as FACE by Galderma. Go-to-market combines product-led growth (the patient self-serve app and surgeon directory) with enterprise field sales targeting aesthetic practices, supplemented by active participation in major industry conferences including IMCAS, ASPS, and OSAPS. By 2025, the platform had been used in 229,911 consultations across 111 countries by 4,517 doctors, forming the largest clinical dataset in the aesthetics industry.

Crisalix reports average consult-to-treatment conversion rates of 86% among surgeon users versus a 36% industry standard, with 99% post-treatment satisfaction and 98% patient recommendation rates — metrics it cites as evidence of clinical and commercial value. The company was founded by CEO Jaime Garcia, has 101-250 employees, and has not disclosed any external funding rounds, suggesting an operationally mature, self-funded or bootstrapped growth profile. Strategic priorities visible in the data include expansion into adjacent aesthetics verticals (notably injectables through the Galderma partnership), geographic deepening in the Americas, Europe, and Asia-Pacific, and continued scaling of the dual B2B/B2C motion.

Name

Crisalix

Legal name

Crisalix S.A.

Website

https://crisalix.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

101–250 employees

Short description

Crisalix is a Swiss health technology company that operates a cloud-based 3D, 4D VR, and AR medical aesthetic imaging platform using proprietary AI to generate personalized surgical visualizations from standard photos. It serves plastic surgeons and aesthetic practitioners through subscription plans and patients directly through a self-serve app, with operations spanning 111 countries.

Ownership category

akta.pro rank

Product category

Medical Aesthetic Imaging Software

NAICS

Software Publishers (51321)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industries

Surgical Visualization & OR Video Integration (4K/3D, Recording, Routing) (HLAHADAD), Healthcare & Clinical Simulation (Surgery, Nursing, EMT, Patient Interaction) (EDAFAJAC)

Keywords

• 3D surgical simulation
• Aesthetic imaging software
• Plastic surgery visualization
• Virtual reality consultation
• Medical simulation platform

Headquarters

HQ city

Lausanne

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

1. Surgeon Subscription Plans: Subscription-based pricing for plastic surgeons and aesthetic practitioners to access the full 3D Business Platform, including in-clinic consultations, remote consultations, patient app integration, and practice management tools. Multiple plan tiers available at different price points.
2. Patient One-Time Simulation Purchase: One-time payment from patients starting at $44 USD to generate 3D simulations of their potential results. Price varies depending on the type of procedure (face, breast, body). This is a self-serve model through my.crisalix.com.
3. Enterprise OEM Partnership (Galderma): White-label/embedded technology partnership where Crisalix's technology powers third-party aesthetic brand applications (e.g., FACE by Galderma), generating licensing and partnership revenue.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Core offering

Crisalix provides a cloud-based 3D and 4D Virtual Reality and Augmented Reality medical aesthetic imaging platform that lets plastic surgeons and patients visualize potential outcomes of cosmetic procedures before surgery. It sells subscription-based 3D Business Platform access to surgeons and aesthetic practitioners and one-time 3D simulations to consumers, while also licensing its technology through OEM/white-label partnerships such as FACE by Galderma.

Product overview

Crisalix offers a unified VR 4D and 3D plastic and cosmetic surgery simulation platform consisting of the core Crisalix Simulation Platform (web-based), the 3D Business Platform (surgeon-facing business and consultation tool), the Crisalix Patient App (consumer mobile/web application), and the MyCrisalix Community (peer support platform). The ecosystem integrates 3D and 4D Virtual Reality and Augmented Reality visualization, AI-powered 3D model generation from photos, and business tools for surgeons to increase consultation conversion rates. Procedures covered include face, breast, and body aesthetic treatments.

Differentiator

Problem solved

Functional benefit

Products and services

• Crisalix VR 4D & 3D Simulation Platform Cloud-based 3D and 4D Virtual Reality and Augmented Reality simulation platform for plastic and cosmetic surgery procedures covering face, breast and body treatments, sold as a subscription service to surgeons and as one-time simulations to patients.
• 3D Business Platform Subscription-based business platform for plastic surgeons and aesthetic practitioners providing in-clinic and remote 3D/4D consultations, conversion analytics, patient app integration and practice management tools.
• Crisalix Patient App Self-serve patient-facing web and mobile application allowing individuals to upload three photos and purchase one-time 3D simulations of potential cosmetic procedure outcomes from home.
• MyCrisalix Community Online community where patients can anonymously share their Crisalix 3D simulations and receive feedback and advice from fellow patients considering aesthetic procedures.
• FACE by Galderma AR application White-label augmented reality application powered by Crisalix technology for Galderma, allowing practitioners and patients to visualize 19 potential injectable treatment outcomes using Galderma's aesthetic portfolio.

Quantifiable outcome

• 86% average consult-to-treatment conversion rate with Crisalix (vs 36% industry standard)
• +5 more outcomes

Named customers15 records

Segments2 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature9 records

Partnerships

One partnership is on record.

• GaldermacoreTechnology or Integration · 26 January 2023Strategic technology partnership where Crisalix developed FACE by Galderma™, an augmented reality application for Galderma's aesthetic practitioner network. The app enables visualization of 19 potential injectable outcomes using products from Galderma's portfolio. Initial availability in US and Brazil (H1 2023), followed by global rollout. Pilot study showed 85% recommendation rate and 91% patient return rate.

Scale indicators9 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• Axis Three (Canfield Scientific): Axis Three was acquired by Canfield Scientific and provides 3D body simulation technology for plastic surgery. It overlaps with Crisalix's breast and body contouring simulations and serves the same surgeon market segment.
• New Look Now: New Look Now provides 3D plastic surgery simulation software to aesthetic practices. It competes head-to-head with Crisalix on breast augmentation, body contouring, and facial procedure visualization for the same surgeon customer base.
• Canfield Scientific (VECTRA): Canfield's VECTRA system is the most established 3D body and face imaging platform for plastic surgery consultations. Both Crisalix and VECTRA target plastic surgeons with pre-op visualization, though Crisalix differentiates via cloud/AI-from-photos vs Canfield's hardware-centric capture stations.

Broad incumbents

• RealSelf: RealSelf is the largest consumer marketplace for cosmetic procedures, connecting patients with aesthetic providers and offering doctor reviews, before/after photos, and procedure education. It overlaps with Crisalix's MyCrisalix community as a patient-discovery channel.

Emerging players

• Surgical Theater: Surgical Theater provides VR surgical planning and patient engagement visualization for complex procedures (neurosurgery, oncology). It is an adjacent technology peer using similar VR/3D visualization for surgical applications, but in different specialties.
• FundamentalVR: FundamentalVR builds VR-based surgical simulation and training platforms using haptic feedback. While it focuses on surgeon training rather than patient consultation, it shares Crisalix's VR/AI visualization technology foundation in healthcare.
• TouchMD: TouchMD is a patient consultation and education platform for aesthetic practices with before/after visualization features. It is an adjacent competitor for the in-clinic consultation workflow, though lighter on AI-driven 3D simulation than Crisalix.
• Symplast: Symplast provides practice management and patient engagement software for plastic surgeons. It competes for the same surgeon subscription wallet but focuses on EMR/PMS rather than visualization, making it an adjacent rather than direct competitor.

Others

• Galderma: Galderma is a major aesthetic pharma company and Crisalix's strategic OEM partner (FACE by Galderma). As a leading injectable and skincare brand, Galderma is both an ecosystem participant and potential indirect competitor with its own practitioner tools.
• Allergan Aesthetics (AbbVie): Allergan Aesthetics, an AbbVie company, is a major breast implant and injectable manufacturer whose products are integrated into Crisalix's 5,000+ implant reference library. It is an ecosystem partner and potential future OEM customer similar to Galderma.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/3Dsimulations
• YouTubeyoutube.com/user/Online3Dsimulation
• Instagraminstagram.com/crisalix
• Facebookfacebook.com/crisalix
• LinkedInlinkedin.com/company/crisalix

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Crisalix